Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

Le Henaff JR, Le Guennec L, Schiro P, Bihan K, Gasnault J, Stankoff B, Taoufik Y, Treiner E, Bensoussan D, Lhomme S, L'Honneur AS, Bonneville F, Shor N, Pourcher V, Pignolet B, Lievin B, Javaux C, Le Guen J, Brissot E, Limouzin PA, Richaud C, Lioure B, Wirth T, Petitgas P, Herbel S, Coustillères F, Rusu EC, Maerten L, Perrot A, Sommet A, Roos-Weil D, Lafaurie M, Weiss N, Martin-Blondel G, THEOREM Study Group

Open source

DOI: 10.1182/bloodadvances.2026020556
Published: 2026 Aug 25
Container: Blood advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2026020556,
  title = {Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.},
  author = {Le Henaff JR and Le Guennec L and Schiro P and Bihan K and Gasnault J and Stankoff B and Taoufik Y and Treiner E and Bensoussan D and Lhomme S and L'Honneur AS and Bonneville F and Shor N and Pourcher V and Pignolet B and Lievin B and Javaux C and Le Guen J and Brissot E and Limouzin PA and Richaud C and Lioure B and Wirth T and Petitgas P and Herbel S and Coustillères F and Rusu EC and Maerten L and Perrot A and Sommet A and Roos-Weil D and Lafaurie M and Weiss N and Martin-Blondel G and THEOREM Study Group},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2026020556},
  url = {https://doi.org/10.1182/bloodadvances.2026020556}
}

RIS

TY  - JOUR
TI  - Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.
AU  - Le Henaff JR
AU  - Le Guennec L
AU  - Schiro P
AU  - Bihan K
AU  - Gasnault J
AU  - Stankoff B
AU  - Taoufik Y
AU  - Treiner E
AU  - Bensoussan D
AU  - Lhomme S
AU  - L'Honneur AS
AU  - Bonneville F
AU  - Shor N
AU  - Pourcher V
AU  - Pignolet B
AU  - Lievin B
AU  - Javaux C
AU  - Le Guen J
AU  - Brissot E
AU  - Limouzin PA
AU  - Richaud C
AU  - Lioure B
AU  - Wirth T
AU  - Petitgas P
AU  - Herbel S
AU  - Coustillères F
AU  - Rusu EC
AU  - Maerten L
AU  - Perrot A
AU  - Sommet A
AU  - Roos-Weil D
AU  - Lafaurie M
AU  - Weiss N
AU  - Martin-Blondel G
AU  - THEOREM Study Group
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2026020556
UR  - https://doi.org/10.1182/bloodadvances.2026020556
ER  -

APA

JR, L. H., L, L. G., P, S., K, B., J, G., B, S., Y, T., E, T., D, B., S, L., AS, L., F, B., N, S., V, P., B, P., B, L., C, J., J, L. G., E, B., PA, L., C, R., B, L., T, W., P, P., S, H., F, C., EC, R., L, M., A, P., A, S., D, R., M, L., N, W., G, M., & Group, T. S. (2026). Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.. Blood advances. https://doi.org/10.1182/bloodadvances.2026020556

Source records

pubmed · retrieved 2026-09-26T12:38:34.587Z